Reproductive Medicine Associates of New York Welcomes Dr. Joseph B. Davis and Dr. Kimberley A. Thornton to Team of Physicians

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility center renowned for its emphasis on providing the latest Assisted Reproductive Technologies (ART) through exceptional, individualized care, is proud to announce the appointment of two physicians to the team. Drs. Joseph B. Davis and Kimberley A. Thornton will treat patients for infertility using basic and advanced methods of reproductive treatments such as intrauterine insemination (IUI), in vitro fertilization (IVF) with comprehensive chromosomal screening (CCS) and preimplantation genetic diagnosis (PGD), and will offer egg donation and fertility preservation options such as egg and embryo freezing to individuals and couples. The physicians will place a specialized focus on care for the LGBTQIA community and for all individuals seeking fertility preservation for medical indication (oncofertility). They are currently accepting new patients at RMA of New York's Downtown (SoHo) practice located at 594 Broadway.

July 12, 2016

New York Magazine Recognizes Six Reproductive Medicine Associates of New York Physicians in their 2016 “Best Doctors” Issue

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility practice globally renowned as a leader in reproductive care and for achieving exceptional birth rates through assisted reproductive technologies, has once again had several of its physicians recognized as the "Best Doctors" in the region by New York Magazine. This is the 15th year in a row that RMA of New York physicians have been named on the list, with this year's honorees being Alan B. Copperman, MD, Lawrence Grunfeld, MD, Benjamin Sandler, MD, Daniel E. Stein, MD, Jeffrey Klein, MD and Natan Bar-Chama, MD.

June 14, 2016

Latest Data Demonstrates IVF Success Rates Incorporating New Treatment Procedures as ART Evolves

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility center globally-renowned for its advanced expertise and innovation in assisted reproductive technology, ranks among an elite group of New York fertility centers publishing in vitro fertilization (IVF) success rates that exceed the U.S. national average. According to annual data released by the Society for Assisted Reproductive Technology (SART) for the year ending December 2014, RMA of New York achieved a live birth rate of 65.9% (n=387)* in women under age 35, compared to the national average of 57%.

May 17, 2016

Slower Blastocysts Demonstrate Lower Implantation Rates Due to Embryo-Endometrial Asynchrony and Not to Reduced Embryonic Competence, Reproductive Medicine Associates of New York Shares Discovery at 2015 ASRM Conference

Reproductive Medicine Associates of New York (RMA of New York) will present data demonstrating that embryo-endometrial asynchrony is accountable for lower implantation rates in slower blastocysts, and not reduced embryonic competence as previously thought. Jorge Rodriguez-Purata, MD presents original research during the ASRM Interactive Session derived from the study entitled "Slower Blastocysts Demonstrate Lower Implantation Rates Due to Embryo-Endometrial Asynchrony and Not By Reduced Embryonic Competence".

October 21, 2015

Does the Uterus Age? Reproductive Medicine Associates of New York Answers the Question at 2015 ASRM Conference

Reproductive Medicine Associates of New York (RMA of New York) will be presenting data regarding determining the impact of age on the uterus at the 71st annual meeting of the American Society for Reproductive Medicine in Baltimore, Maryland.

October 20, 2015

Pregnancy Rates of Fresh versus Cryopreserved Sperm Obtained by Percutaneous Testicular Biopsy Dependent upon Female Age and not the Freezing Process: Reproductive Medicine Associates of New York Shares Research at 2015 ASRM Conference

Reproductive Medicine Associates of New York (RMA of New York) lead researcher Joseph Lee presents original research entitled "Pregnancy Rates of Fresh versus Cryopreserved Sperm Obtained by Percutaneous Testicular Biopsy in Men with Obstructive Azoospermia is Dependent on Female Age" as part of the ASRM Oral Abstract Sessions.

October 20, 2015

Reproductive Medicine Associates of New York Employs Genomic Medicine to Disprove the Theory that Some Couples are Predisposed to Having Predominantly Male or Female Embryos

Globally-recognized fertility center, Reproductive Medicine Associates of New York (RMA of New York) will present original research entitled "Assessing Trends in Embryo Gender After PGS: Are There Male or Female Progeny-Dominant Couples?".

October 20, 2015

Reproductive Medicine Associates of New York Presents 20 Scientific Abstracts at 2015 ASRM Conference in Baltimore, Maryland

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility center, is presenting twenty scientific abstracts at this year's annual ASRM (American Society for Reproductive Medicine) conference in Baltimore, Maryland.

The research presented at this year's conference will include discoveries related to advancements that reduce time to achievement of a healthy pregnancy, assessments of trends in the sex of embryos following preimplantation genetic screening, uses of new technologies to understand the impact of age on uterine function and implantation, the role of embryo-endometrial asynchrony in blastocyst implantation rates, and analysis of reproductive success using surgically obtained fresh versus cryopreserved sperm.

October 19, 2015

Reproductive Medicine Associates of New York Proudly Announces New Study Demonstrating >37% Acceleration in Fertility Patient Journey to Parenthood

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility center, recently completed a study entitled "Patient Treatment Journeys, Then and Now: 12 Years of Clinical Progress", demonstrating that over the twelve-year period between 2003 and 2014, the time span from patients' first consultation to discharge to their obstetrician markedly declined, dropping from 9.1 months to 5.7 months. RMA of New York physicians and researchers involved in the study attribute advances in clinical expertise and assisted reproductive technologies, such as comprehensive chromosomal screening (CCS) of embryos which enable physicians to identify healthy, chromosomally normal embryos with greater than 98% accuracy. By selecting a single optimal embryo for transfer, physicians can achieve higher success rates while reducing occurrences of miscarriage. Through these groundbreaking techniques, patients were able to achieve successful live birth outcomes more rapidly, with multiple gestation rates diminishing by 50% over the same time frame. The decrease in multiple gestations and increase in healthy singleton pregnancies helped patients return to their obstetricians more quickly than ever before.

October 19, 2015

Reproductive Medicine Associates of New York Offers In-Network Fertility Services to GHI/Emblem Health Insurance Members

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility center with an extensive history of providing high quality personalized care for patients requiring reproductive assistance, is proud to announce their status as an in-network provider of reproductive health and fertility services to New York State's largest health insurer with approximately 3.4 million covered lives that include New York City employees who have health insurance coverage with GHI/Emblem Health.

May 19, 2015